Pharmaste Daily: October 6, 2026

Go to the current selection →

DAILY SELECTION · October 6, 2026

Question focus: Medication safety. Drug cards rotate across medication classes.

QUESTION OF THE DAY

Make a choice. Understand the why.

Log in with a confirmed account to save your submitted response. Multiple-response questions require the complete correct set; this is Pharmaste practice feedback, not a claim about NABP scoring.

0 of 1 answered. Your latest responses are used for your recap; you can revisit any set.

Loading your question…

Continue with medication safety →

DRUG OF THE DAY

ondansetron

Serotonin 5-HT3 receptor antagonist antiemetic

Before opening the card, recall one use, one safety check and one counseling point.

Reveal the drug learning card

Names and formulations

  • Ondansetron hydrochloride: film-coated oral tablet

The bound label covers film-coated oral tablets. Other oral dosage forms and injections have separate handling and administration instructions.

Common use

Prevention of nausea and vomiting associated with emetogenic chemotherapy, radiotherapy, or surgery, depending on formulation and regimen.

Mechanism of action

Blocks 5-HT3 receptors centrally and on vagal afferents involved in the vomiting reflex.

Important adverse effects and monitoring

  • Can prolong QT and has been associated with torsades de pointes; correct electrolyte abnormalities and use ECG monitoring in higher-risk patients.
  • Serotonin syndrome has been reported, especially with other serotonergic medicines.
  • May mask progressive ileus or gastric distention after abdominal surgery or chemotherapy.

Patient counseling

  • Take the film-coated tablet exactly as prescribed; do not substitute another dosage form without checking its instructions.
  • Report fainting, palpitations, severe agitation, muscle rigidity, or persistent abdominal distention.

Interaction to recognize

With: apomorphine

Why it matters: The combination has caused profound hypotension and loss of consciousness.

Practical response: Concomitant use is contraindicated.

Check the original sources

  • DailyMed — ondansetron prescribing information

    Sections: 1 Indications and Usage; 4 Contraindications; 5 Warnings and Precautions; 7 Drug Interactions; 12.1 Mechanism of Action; 17 Patient Counseling Information. Source checked 2026-09-13.

Selected learning points; verify current labeling for the complete prescribing information.

Featured from our existing free, reviewed collections. Revisit a concept as it returns in the rotation. Featuring a resource today does not change its original source-check date.

Browse past selections →